Literature DB >> 32341817

Clinical Observation: Effect of a Second Transpositioned Variant in a Family with Autosomal Dominant Ryanodine Receptor-1-Related Disease.

Tomer Avnon1, Ran Svirsky2, Avi Orr-Urtreger2, Liora Sagie3, Aviva Fattal-Valevski3, Yakov Fellig4, Shay Ben-Shachar2.   

Abstract

Mutations in the ryanodine receptor-1 ( RYR1 ) may cause disorders inherited in an autosomal dominant/recessive fashion. Sequencing of RYR1 in an infant of Ashkenazi Jewish descent with severe hypotonia, dislocation of hip, torticollis and scoliosis, and paternal family history of autosomal dominant mild disease. The child was compound heterozygote for a missense variant c.7042G > A inherited from her father associated with autosomal dominant disease, and a missense variant of unknown significance c.5309C > T inherited from an asymptomatic mother. This case raises the possibility of a dominant disease complicated by a second variant in the other allele serving as a modifier. © Thieme Medical Publishers.

Entities:  

Keywords:  central core disease; malignant hyperthermia susceptibility; ryanodine receptor-1 gene

Year:  2019        PMID: 32341817      PMCID: PMC7183409          DOI: 10.1055/s-0039-1698445

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  12 in total

1.  Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.

Authors:  S L Stewart; K Hogan; H Rosenberg; J E Fletcher
Journal:  Clin Genet       Date:  2001-03       Impact factor: 4.438

2.  The spectrum of pathology in central core disease.

Authors:  C A Sewry; C Müller; M Davis; J S M Dwyer; J Dove; G Evans; R Schröder; D Fürst; T Helliwell; N Laing; R C M Quinlivan
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

3.  A novel large deletion in the RYR1 gene in a Belgian family with late-onset and recessive core myopathy.

Authors:  Gauthier Remiche; Hazim Kadhim; Marc Abramowicz; Nicolas Mavroudakis; Nicole Monnier; Joël Lunardi
Journal:  Neuromuscul Disord       Date:  2015-02-09       Impact factor: 4.296

4.  Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.

Authors:  Nyamkhishig Sambuughin; Heather Holley; Sheila Muldoon; Barbara W Brandom; Astrid M de Bantel; Joseph R Tobin; Tom E Nelson; Lev G Goldfarb
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

5.  Dominant versus recessive traits conveyed by allelic mutations - to what extent is nonsense-mediated decay involved?

Authors:  S Ben-Shachar; M Khajavi; M A Withers; C A Shaw; H van Bokhoven; H G Brunner; J R Lupski
Journal:  Clin Genet       Date:  2009-02-19       Impact factor: 4.438

6.  Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia.

Authors:  Norma Beatriz Romero; Nicole Monnier; Louis Viollet; Anne Cortey; Martine Chevallay; Jean Paul Leroy; Joël Lunardi; Michel Fardeau
Journal:  Brain       Date:  2003-08-22       Impact factor: 13.501

7.  Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

Review 9.  Central core disease.

Authors:  Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2007-05-15       Impact factor: 4.123

10.  The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.

Authors:  Guillermo Avila; Kristen M S O'Connell; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2003-03-17       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.